Related Experiment Video
Updated: Dec 12, 2025

Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform
Published on: November 7, 2013
Advances in oligonucleotide drug delivery
Thomas C Roberts1,2, Robert Langer3, Matthew J A Wood4,5
1Department of Paediatrics, University of Oxford, Oxford, UK. thomas.roberts@paediatrics.ox.ac.uk.
Oligonucleotide therapeutics offer versatile gene modulation for various diseases. Overcoming delivery challenges, especially to non-liver tissues, is key for their broader clinical success.
Area of Science:
- Molecular Biology
- Drug Delivery
- Therapeutics
Background:
- Oligonucleotides modulate gene expression through diverse mechanisms like RNA interference and target degradation.
- Approved oligonucleotide drugs highlight their therapeutic potential for numerous indications.
- Efficient delivery, particularly to extrahepatic sites, remains a significant hurdle for oligonucleotide-based therapies.
Purpose of the Study:
- To provide an overview of oligonucleotide-based drug platforms.
- To highlight strategies for overcoming oligonucleotide delivery challenges.
- To focus on chemical modification, bioconjugation, and nanocarrier approaches.
Main Methods:
- Review of chemical modification strategies for oligonucleotides.
- Analysis of bioconjugation techniques to enhance oligonucleotide properties.
- Examination of nanocarrier systems for oligonucleotide delivery.
- Focus on approaches targeting extrahepatic tissues.
Main Results:
- Oligonucleotide platforms utilize chemical modifications, bioconjugation, and nanocarriers to improve delivery.
- These strategies aim to enhance stability, targeting, and cellular uptake of oligonucleotides.
- Progress in these areas is crucial for expanding therapeutic applications beyond the liver.
Conclusions:
- Chemical modification, bioconjugation, and nanocarriers are key strategies to enhance oligonucleotide delivery.
- Addressing delivery limitations is essential for realizing the full therapeutic potential of oligonucleotides.
- Further advancements are needed to enable efficient oligonucleotide-based treatments for a wider range of diseases.
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Drug Delivery: Enteral Route
Bioavailability Enhancement: Drug Permeability Enhancement
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...

